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 The immune system must balance the generation of a diverse T cell repertoire 
responsive to various pathogens versus the prevention of tissue destruction by self-antigen-
specific T cells. Thymic dendritic cells (DC) are known to eliminate self-antigen-specific 
thymocytes. Despite this, little is known about the factors regulating thymic DC homeostasis 
and antigen presentation, which were investigated in this study. 
 In the first part of our study, it was hypothesized that factors within the thymus 
regulate thymic DC homeostasis. Specifically, the role of CD4+ and CD8+ single-positive 
thymocytes (SP) was investigated. In mice lacking SP, significantly fewer DC resided in the 
steady-state thymus, and those DC displayed a less mature phenotype (e.g. reduced 
expression of major histocompatibility [MHC] and T cell costimulatory molecules) and a 
markedly reduced T cell stimulatory capacity compared to wild-type thymic DC. When 
CD4+SP or CD8+SP were individually restored, thymic DC activation status was only 
recovered under conditions where antigen-specific interactions with SP occurred. During 
antigen-specific interactions, the restoration of thymic DC activation status depended on 
CD40 ligand from CD4+SP but not CD8+SP. Thus, thymic DC homeostasis is regulated by 
antigen-specific interactions with CD4+SP or CD8+SP by distinct molecular mechanisms. 
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 To promote thymic tolerance, thymic DC must acquire and present cognate antigens 
to thymocytes; for example, through “nibbling” of antigens from thymic epithelial cells 
(TEC). However, the mechanism by which this occurs is largely unknown. Using an in vitro 
co-culture system, thymic DC nibbling of MHC was investigated. Thymic DC efficiently 
nibbled MHC from TEC and DC, but not from B cells. It was hypothesized that the cell 
surface organization of MHC may regulate nibbling by thymic DC. Specifically, the role of 
lipid rafts was analyzed. Thymic DC acquired lipid rafts from TEC, DC, and B cells. 
Interestingly, when another B cell surface molecule, immunoglobulin M (IgM), was actively 
clustered to lipid rafts, nibbling of IgM occurred. These data suggest that cell surface 
organization of clustered molecules may facilitate acquisition by thymic DC via nibbling. 
Together, the studies presented herein provide novel insight into the factors regulating 
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CHAPTER 1: Introduction 
1.1 Self/Non-Self Recognition 
 The fundamental responsibility of the immune system is to discern between the 
benign self and potentially pathogenic non-self or altered self, and many mechanisms exist to 
facilitate this process. The immune system is broadly segregated into two arms: innate and 
adaptive immunity. Each of these arms serves both unique and collaborative roles during an 
immune response. The innate immune system responds rapidly to stimuli, and is often 
responsible for priming of a subsequent adaptive immune response (1). Self/non-self 
discrimination is achieved through the function of various pattern recognition receptors 
(PRR), including members of the toll-like receptor (TLR) family (2), nucleotide-binding 
oligomerization domain receptor family (3), and RIG-I-like receptor family (4). These PRR 
typically recognize common, conserved, and often repetitive structures found ubiquitously 
among pathogens, including bacteria, viruses, and fungi, but not found as part of endogenous 
self-proteins or host cells. In contrast, the adaptive immune system responds more slowly to 
stimuli, typically requiring several days to mount an initial response. However, adaptive 
immune responses are highly specific, with an individual T or B cell typically recognizing 
only one antigen (Ag). Self/non-self recognition in the adaptive immune system is due to the 
expression of unique Ag receptors, namely the T cell receptor (TCR) or B cell receptor 
(BCR). The TCR recognizes small antigenic peptides presented in the context of a major 
histocompatibility complex (MHC) molecule on the surface of Ag-presenting cells (APC) 
(5). The BCR recognizes three-dimensional soluble Ag, or Ag bound to receptors such as 
complement receptors or Fc receptors, that binds directly to the BCR (6). While an individual 
T or B cell generally recognizes only one Ag, many unique T and B cells are generated, 
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affording immense diversity of Ag recognition (7, 8). Importantly, adaptive immunity is 
further characterized by the generation of long-lived immunological memory (9, 10). 
Memory immune responses can be rapidly recalled upon infection with a previously 
encountered pathogen, providing enhanced responsiveness and highly effective protection 
against infection. Thus, proper self/non-self discrimination is an essential feature of an 
effective immune system. 
 
1.2 Immunological Tolerance 
 A critical feature afforded when self/non-self recognition properly functions is the 
establishment of immunological self-tolerance. Tolerance takes many cell type-dependent 
forms; in the context of this study, T cell tolerance, specifically of T cells bearing a 
conventional heterodimeric  TCR, is most important.  
1.2.1 Central T cell Tolerance 
An early checkpoint for enforcement of T cell tolerance occurs during T cell 
development in the thymus. Immature T cells, referred to as thymocytes, will spend up to 2-3 
weeks in the thymus before entering the peripheral immune system as mature T cells (11). 
Throughout this time period, thymocytes progress through various stages of development, 
and many thymocytes (>95%) will die within the thymus (12). All thymocytes originate from 
blood-borne hematopoietic precursor cells (13), which seed the thymus and are the source of 
the earliest stage of identifiable thymocytes present in the thymic cortex, CD4-CD8- double-
negative (DN) thymocytes. To progress through this stage, thymocytes must successfully 
complete beta selection, which entails productive rearrangement of TCR chain loci and 
subsequent cell surface expression of TCR chain along with an immature pre-TCR chain 
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(14, 15). Completion of beta selection promotes upregulation of the two T cell coreceptor 
molecules, CD4 and CD8, and differentiation into CD4+CD8+ double-positive (DP) 
thymocytes. DP thymocytes will begin to rearrange TCR chain loci, and cells that express a 
productive TCR chain, and thus a complete  TCR, will enter into positive selection. 
Positive selection tests the ability of DP thymocytes to interact with self-MHC displayed by 
cortical thymic epithelial cells (cTEC), the primary APC in the thymic cortex (16). The 
ability to recognize self-MHC is critical to T cell function, as Ag encountered in the 
peripheral immune system will be presented in the context of this same self-MHC. Thus, this 
process “positively” selects for thymocytes expressing a functional TCR.  
After successful positive selection, thymocytes undergo a number of developmental 
events. These include differentiation of DP into either CD4+CD8- or CD4-CD8+ single-
positive (SP) thymocytes and expression of certain chemokine receptors and adhesion 
molecules that facilitate trafficking into the other subanatomical niche within the thymus, the 
medulla (17). In the thymic medulla, thymocytes are scanned for reactivity to self-Ag. 
Thymocytes that strongly recognize self-Ag presented by medullary thymic epithelial cells 
(mTEC) (18), dendritic cells (DC) (19), and possibly B cells (20) undergo apoptosis in a 
process called negative selection (21). Negative selection ensures that self-reactivity is 
purged from the T cell repertoire. T cells that do not strongly recognize self-Ag fail to 
receive a pro-apoptotic signal, and subsequently emigrate from the thymus to populate the 
peripheral immune system as mature T cells. Alternatively, cells that recognize self-Ag with 
“intermediate” strength may be induced into a distinct T cell lineage, namely regulatory T 
cells (Treg) that express the forkhead box P3 (FoxP3) transcription factor (22). These cells 
are critical for the maintenance of peripheral immune tolerance (discussed below) and the 
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resolution of T cell responses after eradication of a pathogen. While the extensive process of 
thymocyte development can be quite effective, full deletional tolerance of all self-reactivity 
is not typically achieved (23). Thus, additional mechanisms of tolerance must exist. 
1.2.2 Peripheral T cell Tolerance 
 While the overwhelming majority of self-reactive T cells are purged during negative 
selection, some self-reactive cells escape this process. If left unchecked, these T cells could 
potentially cause tissue destruction leading to autoimmunity. However, several mechanisms 
of peripheral tolerance exist to prevent this from occurring. Efficient activation of naïve T 
cells requires signals induced by the TCR following binding of peptide-MHC complexes and 
by the co-stimulatory molecule CD28 via binding of APC-derived CD80 or CD86 (24). 
Additionally, the pro-survival cytokine interleukin- (IL-) 2 promotes T cell proliferation, as 
the IL-2 receptor is upregulated upon TCR ligation (25). Subsequently, additional cytokines 
are typically required to foster T cell effector (Teff) differentiation. For example, interleukin- 
(IL-) 12 promotes generation of interferon (IFN) -producing T helper (Th) 1 cells (26), 
while IL-4 promotes generation of IL-4-, IL-5-, and IL-13-producing Th2 cells (27). 
Stimulation of naïve T cells through the TCR alone, without CD28 costimulation or cytokine 
signals, results in incomplete activation and T cell anergy (28), a state of functional 
nonresponsiveness. On the other hand suppression of established pathogenic Teff is mediated 
primarily by Treg. Treg typically produce immunomodulatory cytokines, such as IL-10 and 
transforming growth factor beta (TGF), which block Teff reactivity (29). Furthermore, Treg 
can directly suppress Teff via expression of various inhibitory cell surface receptors (30), and 
can also limit Teff activation by preferentially occupying APC and thus limiting Teff APC 
access (31). Finally, suppression of Teff also occurs through APC, especially tolerogenic DC. 
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Steady-state DC exhibit an immature phenotype marked by expression of low levels of T cell 
costimulatory molecules, such as CD80 and CD86, and the lack of production of 
proinflammatory cytokines (32). Thus, T cells that interact with immature DC do not receive 
strong activating signals. Additionally, DC can produce immunomodulatory cytokines to 
dampen T cell activation (33). Together, these mechanisms of peripheral tolerance help 
prevent autoimmunity that could be caused by self-reactive T cells that have escaped central 
tolerance. 
 
1.3 Dendritic cells as central orchestrators of tolerance and immunity 
 Implicit throughout the description of immune tolerance is the complete dependence 
of T cells on APC for both development and peripheral activation. While many cell types can 
be APC under certain conditions, DC are the primary, professional APC of the immune 
system (34). DC constitutively express both MHC I and MHC II, which endows DC with the 
ability to effectively stimulate both CD8+ and CD4+ T cells, respectively. However, as 
mentioned above, steady-state immature DC do not prime T cell immunity. In fact, targeting 
Ag to resting DC induces potent, long-lived Ag-specific T cell tolerance (35). In order to 
prime an effective T cell response, DC must first be activated. DC express a broad array of 
PRR (36), permitting the recognition of many diverse pathogens. Additionally, immature DC 
are highly phagocytic and thus capable of acquiring extracellular Ag for processing and 
presentation to T cells (37). However, the context of Ag acquisition is critical to the resulting 
DC function. In the absence of activating signals, such as those through PRR or other danger 
signals, DC phagocytosis of extracellular debris, especially in the form of apoptotic cells, 
further reinforces DC quiescence (38). Indeed, DC that bind apoptotic cells become 
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refractory to subsequent inflammatory stimuli (39, 40), and elimination of cellular receptors 
for apoptotic cells abrogates this phenomenon (41).  
Once the proper inflammatory context has been perceived, a complex process of DC 
activation and maturation occurs. Ingested Ag will be processed and loaded onto MHC 
molecules, which are shuttled to the cell surface (42, 43), leading to robust upregulation of 
cell surface MHC expression. Moreover, inflammatory stimuli significantly upregulate the 
costimulatory molecules CD80 and CD86 on DC (36), thus allowing DC to provide the 
necessary costimulatory signal to T cells. Depending on the initial inflammatory stimuli, 
various cytokines including tumor necrosis factor (TNF) and IL-12 will be produced as well 
(44). As a whole, this process promotes maturation of DC from maintainers of tolerance to 
primers of T cell immunity. Furthermore, DC:T cell interactions result in feedback to DC, for 
example via T cell-expressed CD40 ligand (CD40L) interaction with DC-expressed CD40, 
which extends DC activation and promotes DC survival (45). However, most DC have a 
relatively quick turnover rate (3-5 days for most lymphoid-resident DC) (46, 47), which may 
help ensure that DC-driven T cell immune responses do not continue indefinitely. This 
resolution phase of an immune response is critical; a rampant, unchecked immune response 
may lead to unnecessary and potentially harmful damage to the host. Indeed, DC themselves 
are also responsive to immunomodulatory cytokines, for example IL-10 and TGF (48–50). 
Overall, DC activation and maturation is a complex and heavily regulated process, and the 
tight regulation of DC maturation places DC at the core of both tolerance and immunity. 
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1.4 DC development and heterogeneity 
 While all DC possess many common characteristics, DC are in fact a heterogeneous 
population of cells that are typically divided into multiple subsets, the divergence of which 
occurs at various points during DC development. Like all hematopoietic cells, DC are 
derived from hematopoietic stem cells residing in the bone marrow (BM) (51). DC initially 
diverge from lymphoid (T, B, and natural killer) cells upon the development of the 
macrophage and DC precursor cell, which gives rise to both monocyte/macrophage lineage 
cells and DC. Subsequent differentiation leads to a common DC precursor (CDP) cell that 
develops into the 2 major DC subsets: classical or conventional DC (cDC) and plasmacytoid 
DC (pDC) (52). Before development into fully differentiated cDC, CDP will become pre-
cDC. Unlike all prior developmental stages, pre-cDC can be found in both the BM and 
secondary lymphoid organs such as the spleen and lymph nodes (LN). At this stage, pre-cDC 
are heavily dependent upon recognition of the fms-like tyrosine kinase receptor-3 (Flt3) 
ligand to achieve full differentiation into cDC (53). Subsequently, cDC lose expression of 
Flt3 and are most reliably identified by expression of the pan-DC surface marker CD11c 
(integrin x), which is expressed by both cDC and pDC, albeit at lower levels on pDC. This 
developmental process lays the foundation for further functional specialization of terminally-
differentiated DC subsets. 
 Many different subsets can be identified within the cDC population, and the features 
that distinguish these populations vary from organ-to-organ. In secondary lymphoid organs 
such as the spleen and LN, cDC are broadly delineated into resident and migratory cDC. 
Resident cDC are always present, and are typically divided into 2 major subsets based on the 
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expression of CD8 (54). While surface marker expression is the means to separate these 
populations, the subsets are considered distinct due to unique functional capacities. For 
example, CD8+ cDC are well-known for the ability of cross-presentation (55), a mechanism 
by which extracellular Ag—which is typically processed for loading onto MHC II—is 
shuttled into the MHC I processing pathway for subsequent presentation to CD8+ T cells. 
Additionally, CD8+ cDC are also highly efficient at the uptake of apoptotic cells (56). On 
the other hand, CD8- cDC may be specialized for presentation of Ag to CD4+ T cells (57). 
Migratory DC enter LN through lymph vessels draining the associated tissue site. It is 
noteworthy that most migratory DC express particularly high levels of MHC II, perhaps 
indicating that the ability to migrate to the LN is preferentially bestowed upon activated DC 
(58).  
 pDC are also resident in secondary lymphoid organs and appear to be specialized in 
antiviral defense. Unlike most cDC populations, which express moderate levels of MHC II in 
the steady-state, resting pDC express minimal MHC II. Upon encountering the appropriate 
signal, especially viral signatures such as double-stranded or single-stranded RNA or 
unmethylated CpG DNA, pDC can mature and adopt many of the surface features of mature 
cDC, especially high levels of MHC and costimulatory molecule expression (59). However, 
the most notable contribution of pDC to antiviral immunity is through the production of type 
I IFN (60), which promotes an antiviral state in host cells that helps defend against viral 
infection. Hence, DC heterogeneity is an important feature that allows these cells to tailor the 
immune response in a manner appropriate for the given situation. 
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1.5 DC in central tolerance 
 While DC are highly effective at initiating an adaptive T cell response, DC also make 
crucial contributions to T cell central tolerance during development in the thymus. The first 
indication of this came from a seminal work by Marrack and colleagues. In this study, it was 
shown definitively that BM-derived cells were sufficient to induce tolerance to self-MHC 
(61). A second critical study showed that MHC expression in the thymic medulla was 
essential for the maintenance of T cell self-tolerance (62). Though both important early 
studies, each study also had its shortcomings. While BM-derived cells were shown to be 
sufficient to induce self-MHC tolerance, the identity of the BM-derived population remained 
a mystery. In the second study, MHC expression was targeted only to the thymic cortex, thus 
providing positive selection of T cells but no tolerizing input from medullary APC 
populations. However, several different APC populations inhabit the thymic medulla, 
including mTEC and thymic DC. Definitive proof that thymic DC contribute to negative 
selection of thymocytes was then provided by a study using targeted expression of MHC II 
only to DC (19). Importantly, this study also showed that thymic DC could not induce 
positive selection of thymocytes, further emphasizing that positive selection was the realm of 
cortical APC such as cTEC and negative selection the realm of medullary APC such as 
mTEC and DC. These critical studies provide a foundation upon which subsequent 
refinements to our understanding of the role of APC in central tolerance have been made. 
 
1.6 Thymic DC subsets 
 As in other lymphoid organs, thymic DC are heterogeneous. This fact complicated 
early studies attempting to delineate distinct populations of thymic DC. Attempts to 
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segregate thymic DC into the commonly used CD8+ and CD8- populations were 
confounded by the observation that thymic DC pickup CD8 from thymocytes (63). By use 
of a second cell surface molecule, signal regulatory protein alpha (SIRP), it was discovered 
that two distinct populations of thymic cDC exist: a SIRP+CD8lo population and SIRP-
CD8+ population (64). Additionally, pDC are found in the thymus (65), yielding 3 major 
subsets of thymic DC. Many subsequent studies have focused on the unique properties of 
these 3 populations. 
 
1.7 Thymic DC ontogeny 
 As with all other DC, thymic DC are hematopoietic in origin and dependent on BM 
precursors for their development. However, whereas most lymphoid resident DC complete 
full development within the bone marrow itself (51), thymic DC were initially described as 
developing from an intrathymic precursor that also gives rise to T cells (66). While it is 
generally accepted that thymic CD8+ cDC develop intrathymically, whether the immediate 
precursor also retains T cell potential has been challenged (67). Nonetheless, the intrathymic 
origin of this DC population suggests that it is specialized for functions necessary for T cell 
tolerance. On the other hand, thymic SIRP+ cDC and pDC do not develop within the 
thymus but rather are migratory populations derived from the bloodstream (68–70). 
Implications of this observation for central tolerance will be discussed below. In whole, it is 
tempting to speculate that this diversity in thymic DC origins exists as a mechanism to 
expand the range of Ag to which thymic DC can induce self-tolerance. 
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1.8 Thymic DC and antigen acquisition 
 Thymic DC are widely considered to be primary contributors to the clonal deletion of 
self-reactive thymocytes; thymic DC expression of MHC II is sufficient to purge self-reactive 
CD4+ T cells (19). How thymic DC acquire Ag for presentation in the thymus remains poorly 
understood. Thymic DC retain high expression of proteosomal proteins necessary for Ag 
processing and presentation (71, 72). Thus, thymic DC should be capable of constitutive 
processing and presentation of intracellular self-Ag via MHC I. It is also tempting to 
speculate that the large number of dying thymocytes would provide a source of extracellular 
self-Ag for presentation via MHC II. However, this still leaves a significant portion of self-
Ag—particularly those unique to specific tissues—unexpressed by thymic DC. Many 
peripheral tissue Ag (PTA) are expressed in the thymus under control of the autoimmune 
regulator (AIRE) protein (73). While thymic DC may express AIRE (74), the level of 
expression is significantly reduced compared to mTEC, the primary AIRE-expressing cell 
population in the thymus. However, AIRE-dependent PTA may be acquired by DC via 
intracellular transfer of PTA from mTEC (75–78). Indeed, acquisition of mTEC-derived Ag 
by thymic DC plays an important role in central tolerance, though mTEC are also capable of 
direct presentation of Ag for central tolerance induction (79). The range of Ag to which DC 
can induce central tolerance is further expanded by the ability of DC to acquire Ag via the 
bloodstream (80–82). Finally, migratory DC populations ferry peripheral Ag to the thymus 
for presentation to developing thymocytes (69, 70, 83). Thus, thymic DC acquire Ag in 
diverse ways to facilitate the elimination of self-reactive thymocytes. 
 It is worthwhile to note that, while DC are sufficient to induce tolerance to self-MHC 
and are capable of clonal deletion of self-reactive thymocytes, proof that DC are absolutely 
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required for the maintenance of central tolerance remains controversial. This is primarily 
derived from two analogous studies in which constitutive ablation of DC was achieved (84, 
85). In one study, T cell development was normal in the absence of DC, but the mice 
succumbed to a fatal myeloproliferative syndrome (84). It was concluded that thymic DC are 
therefore dispensable for T cell development and central tolerance. In the second study, an 
increased frequency of CD4SP thymocytes was observed and CD4+ T cells infiltrated 
multiple organs, resulting in fatal autoimmunity in DC-less mice (85). This indicated that 
thymic DC are critical for the maintenance of central and peripheral T cell tolerance. While 
the results of these two studies remain contentious, it should be noted that the mice used in 
these studies were generated independently. Moreover, the two studies show differing 
deletion efficiencies of DC subpopulations. These factors could very well explain the 
discrepant findings. Thus, the relative contribution of thymic DC and other medullary APC 
populations requires continued investigation. 
 
1.9 Thymic DC and thymic Treg development 
 Elimination of self-reactive thymocytes via clonal deletion is only one way in which 
thymic processes help ensure self-tolerance. Another important function of the thymus is to 
promote the development of FoxP3-expressing thymus-derived Treg (tTreg, formerly 
referred to as natural Treg) (22, 86). DC have been shown to induce tTreg development, 
though the factors involved may vary in mice versus humans. In humans, DC conditioned by 
thymic stromal lymphopoietin (TSLP) can induce tTreg in a mechanism involving Ag-
specific MHC-TCR interaction and CD80/CD86 costimulation (87). This function is not 
unique to thymic cDC; human thymic pDC can also induce tTreg (88, 89). In the case of 
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thymic pDC, it seems that TSLP or CD40L “license” pDC to induce tTreg. It is currently 
unclear whether additional factors are involved in the licensing of human thymic DC (cDC or 
pDC) to induce tTreg. It is also unclear whether other human thymic APC populations induce 
tTreg development. In murine studies, it has become clear that tTreg development is fostered 
by either thymic DC or mTEC (79, 90–93). Unlike with human DC, the ability to induce 
tTreg development seems to be mostly restricted to the SIRP+ cDC population (94). The 
reasons for this specialization are unclear, however thymic SIRP+ cDC are more mature 
than CD8+ cDC or pDC and thus may more efficiently provide TCR ligation and 
costimulatory signals, both of which are critical for tTreg development (92, 95, 96). Thus, 
whether by clonal deletion of self-reactive thymocytes or induction of tolerance-promoting 
tTreg cells, thymic DC make crucial contributions to the maintenance of T cell homeostasis. 
 
1.10 Cellular crosstalk in the thymus 
 Since both clonal deletion and tTreg cell induction are thought to require intermediate 
to high strength signals via the TCR and possibly costimulatory molecules (97), it is 
reasonable to speculate that expression of MHC and costimulatory molecules in the thymus 
may be a tightly regulated process. This is certainly the case for mTEC, which have been 
extensively studied in this context. It has been shown that mTEC progress through a step-
wise development process, which ultimately results in the generation of fully mature 
CD80hiMHC IIhiAIRE+ mTEC (so-called mTEChi) (98). However, this process is not under 
intrinsic mTEC control but rather requires input from various different thymic cell 
populations. The majority of this input comes in the form of ligation of various tumor 
necrosis factor superfamily (TNFSF) receptors expressed by mTEC progenitors. One of the 
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major TNFSF family members involved in mTEC development is receptor activator of 
nuclear factor kappa B (RANK) and its ligand, RANKL. Mice deficient in the expression of 
either RANK or RANKL have sharply reduced overall numbers of mTEC and mTEChi (99–
102). It is tempting to speculate that RANKL/RANK interactions may be the earliest form of 
crosstalk critical to mTEC development. This interaction can be provided by lymphoid tissue 
inducer cells and invariant  T cell precursors (99, 102), both of which inhabit the 
embryonic thymus very early in development, prior to most conventional thymocyte 
populations. RANKL can also be provided by positively-selected  thymocytes (101), and 
thus likely contributes to mTEC development at various stages of mouse ontogeny. 
Subsequently, CD40/CD40L become critical in controlling mTEC cellularity, possibly 
through promoting mTEC proliferation (100, 103, 104). It is unsurprising that CD40L 
controls later stages of mTEC development; significant CD40L expression is not detected 
until the TCR+CD4+CD8- stage of  thymocyte development (101, 104). Importantly, T 
cells generated in mice lacking RANK and CD40 likely have increased autoreactivity; 
adoptive transfer of peripheral T cells into athymic nude mice resulted in autoimmunity 
(100). Overall, cellular crosstalk is an important process necessary for normal mTEC 
development and the maintenance of immune homeostasis. 
 
1.11 Goals of this study and study findings 
 It has become clear that thymic DC are crucial contributors to T cell central tolerance 
and Treg development. While many of the mechanisms that regulate T cell development and 
thymic selection remain incompletely understood, it is generally accepted that the strength of 
signal received by developing thymocytes is critical in determining the fate of these cells. 
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Certainly, intrinsic properties of a given TCR will play a strong role in regulating the relative 
strength of signal perceived by a thymocyte. However, the activation status—levels of 
expression of T cell stimulatory molecules such as MHC and CD80/86—of thymic APC is 
also expected to impact thymocyte selection. Despite this, very little is known about the 
factors that regulate thymic DC homeostasis. In the first part of our studies, we show that 
thymic DC homeostasis is regulated by interactions with SP thymocytes. In TCR-deficient 
(NOD.TCR-/-) mice, which lack SP thymocytes, thymic DC phenotype, function, and 
cellularity were significantly reduced relative to wild-type (WT) NOD thymic DC. 
Subsequently, we show that induction of Ag-specific interactions between thymic DC and 
either CD4+ or CD8+ thymocytes fully restored thymic DC phenotype via CD40L-dependent 
and CD40L-independent mechanisms, respectively. Together, these findings uncover a 
previously unknown mechanism of thymocyte:DC crosstalk that is necessary for normal 
thymic DC homeostasis. 
 Another topic in thymic DC biology that remains poorly understood is the nature of 
the Ag thymic DC present to thymocytes. Unlike mature mTEC, thymic DC are not known to 
ectopically express a significant amount of PTA. Notably, however, thymic DC are critical 
for the presentation and functional deletion of thymocytes specific for at least some mTEC-
expressed PTA in model systems via acquisition of mTEC Ag (“nibbling” or “cross-
dressing”). Though the significance of this process in vivo has been demonstrated, it is 
unclear whether specific mechanisms govern the acquisition of Ag by thymic DC via 
nibbling. In the second part of our studies, we investigated the mechanisms by which thymic 
DC nibbling occurs primarily through the use of an in vitro culture system relying on 
differential MHC haplotype expression. Using this system, thymic DC acquisition of 
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functional MHC I and MHC II from mTEC and other DC but, surprisingly, not from splenic 
B cells was readily observed. Interestingly, membrane fragments known to be enriched in 
MHC II, namely lipid rafts, could be acquired from both mTEC and B cells. When a B cell 
surface molecule, immunoglobulin (Ig) M, was induced into lipid rafts by antibody (Ab) 
crosslinking, DC could acquire IgM. Therefore, dense clustering of surface molecules into 




CHAPTER 2:  Antigen-specific thymocyte feedback regulates homeostatic thymic 
conventional dendritic cell maturation1 
2.1 Summary 
Thymic dendritic cells (DC) mediate self-tolerance by presenting self-peptides to and 
depleting autoreactive thymocytes. Despite a significant role in negative selection, the events 
regulating thymic DC maturation and function under steady-state conditions are poorly 
understood. We report that crosstalk with thymocytes regulates thymic conventional DC 
(cDC) numbers, phenotype, and function. In mice lacking TCR-expressing thymocytes, 
thymic cDC were reduced and exhibited a less mature phenotype. Furthermore, thymic cDC 
in TCR transgenic mice lacking cognate antigen expression in the thymus were also 
immature; notably, however, thymic cDC maturation was reestablished by an Ag-specific 
cognate interaction with CD4+ or CD8+ single-positive thymocytes (SP). Blockade of CD40L 
during Ag-specific interactions with CD4SP but not CD8SP limited the effect on cDC 
maturation. Together, these novel findings demonstrate that homeostatic maturation and 
function of thymic cDC is regulated by feedback delivered by CD4SP and CD8SP via 
distinct mechanisms during a cognate Ag-specific interaction.  
                                                 
1This work was originally published in The Journal of Immunology. Citation: Spidale, N.A., B. Wang, and R. 
Tisch. 2014. Cutting Edge:  Antigen-specific thymocyte feedback regulates homeostatic thymic conventional 




Thymocyte maturation and self-tolerance is induced by interactions with thymus-
resident APC. Cortical thymic epithelial cells promote the positive selection of CD4+CD8+ 
double-positive thymocytes (DP), whereas medullary thymic epithelial cells (mTEC), which 
express multiple peripheral-tissue Ag, drive negative selection of autoreactive single-positive 
thymocytes (SP) (16). Thymic DC also induce negative selection of self-reactive thymocytes 
(19, 70, 105, 106) as well as promote natural regulatory T cell development (87, 88, 94, 106). 
Moreover, ablation of DC in mice has been shown to lead to either autoimmunity due to 
aberrant thymic tolerance (85) or dysregulation of peripheral immune homeostasis (84, 107), 
highlighting the broad regulatory function of DC. 
DC in the thymus include three major subsets: CD8+ cDC, signal regulatory protein 
+ (SIRP+) cDC, and plasmacytoid DC(pDC) (64). Migratory SIRP+ cDC and pDC ferry 
peripheral self-Ag to the thymus to mediate negative selection (69, 70, 83). Additionally, 
SIRP+ and intrathymically-developed CD8+ cDC uptake soluble blood-borne Ag and 
subsequently process and present self-epitopes to thymocytes (64, 80–82). Furthermore, 
thymic DC can acquire Ag expressed by mTEC (75–78), which expands the self-Ag pool 
presented by thymic DC. Interestingly, thymic DC express elevated levels of MHC and 
costimulatory molecules, which correlate with enhanced T cell stimulatory capacity relative 
to resting peripheral (e.g. splenic) DC (94, 106, 108, 109). The latter is expected to enhance 
the efficacy of thymic negative selection. Little is known, however, about the factors that 
regulate thymic DC homeostasis. In this article, we show that increased activation and 
maturation of steady-state thymic DC required Ag-specific interactions with CD4SP or 
CD8SP. CD4SP-derived feedback, but not CD8SP-derived feedback, was abrogated by 
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blockade of CD40L. Thus, DC:thymocyte crosstalk is critical for the maintenance of thymic 
DC phenotypic activation and function.  
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2.3 Materials and Methods 
2.3.1 Mice 
NOD/LtJ (NOD), NOD/BDC2.5, NOD.TCR-/-, NOD/BDC2.5 x NOD.TCR-/- 
(BDC2.5/TCR-/-), and NOD.Clone 4 TCR transgenic x NOD.scid (CL4.scid) mice have 
been described (110, 111) and were housed in specific pathogen-free facilities at the 
University of North Carolina at Chapel Hill. All procedures were approved by the University 
of North Carolina at Chapel Hill Institutional Animal Care and Use Committee.  
 
2.3.2 Cell isolation and culture 
Thymi from 3- to 6-wk old mice were digested with 1 mg/mL collagenase D and 20 
g/mL DNAse I (Roche) for 30 min at room temperature. EDTA was included for the final 5 
min. DC were enriched using an OptiPrep gradient (Axis-Shield) and purified (>95%) via 
fluorescence-activated cell sorting (FACS). Splenic T cells were purified using a CD4+ 
Isolation Kit (Miltenyi Biotec).  
To measure T cell proliferation, T cells were labeled with 5 M CellTrace Violet 
(Invitrogen), co-cultured with peptide-pulsed DC at a 1:10 DC:T cell ratio for 3 d, and 
assessed by FACS. Division Index was calculated with FlowJo software (TreeStar). 
 
2.3.3 FACS 
Monoclonal Ab (mAb) and streptavidin were purchased from BD Biosciences, 
eBioscience, BioLegend, or Invitrogen. Cells were incubated with CD16/32 (2.4G2) to 
block Fc receptors prior to Ab staining. Dead cells were excluded using propidium iodide, 
DAPI, or LIVE/DEAD stain (Invitrogen). For IL-12 (p40) staining, DC were cultured for 2-4 
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h with 10 g/mL Brefeldin A (Sigma-Aldrich), fixed and permeabilized with BD 
Cytofix/Cytoperm solutions. Data were acquired on a BD LSR II and analyzed with FlowJo 
software.  
 
2.3.4 DC localization 
Thymic sections (7 m) were stained with rabbit Keratin 5 (Covance), biotin 
DEC-205 (BioLegend), and Alexa Fluor 647 CD11c (eBioscience) followed by Alexa 
Fluor 488 goat rabbit IgG and Alexa Fluor 594 streptavidin (both from Invitrogen). Images 
(10x) were acquired using the 10x/0.45 numerical aperture objective of an LSM 710 spectral 
laser-scanning confocal microscope and ZEN software (Zeiss). Image analysis was 
performed in ImageJ: channels were split and converted to binary with automatic 
thresholding (negative = 0; positive = 255). Mean intensity of CD11c was measured for a 
given area of Keratin 5+ medulla or DEC-205+ cortex. This was performed for 3 separate 
medulla and cortex zones per image, averaged, and recorded as 1 data point.  
 
2.3.5 mAb production and peptides 
The CD40L blocking mAb MR1 (ATCC CRL-2580) and CD40 agonist mAb 
1C10 were produced in-house. Control animals received either PBS or rat IgG2a isotype 
control (2A3, BioXCell). The sBDC mimetic peptide (RTRPLWVRME) and influenza 
hemagglutinin (HA, IYSTVASSL) peptides were produced at >95% purity by the UNC 
High-Throughput Peptide Synthesis and Array Facility.  
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2.3.6 Analysis of BrdU incorporation 
  To analyze DC turnover, mice received an initial intraperitoneal (i.p.) injection of 1 
mg 5-bromo-2’-deoxyuridine (BrdU) and then 0.8 mg/ml BrdU in sterile drinking water 
containing 1% glucose to overcome taste aversion. Water was replaced daily throughout the 
assay duration. BrdU was detected via FACS using the PE BrdU Set (clone 3D4, BD 
Biosciences) following previously described methods (46, 112). Gating for BrdU+ cells was 
always based on cells stained with the BrdU mAb but not administered BrdU. Isotype 
control staining gave similar results (unpublished observations). 
 
2.3.7 Statistical analysis  
Statistical analyses were performed using GraphPad Prism software. Unless otherwise 
indicated, significance was calculated by ANOVA with Bonferroni posttest. 
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2.4 Results 
2.4.1 SP are necessary for normal thymic cDC numbers, phenotype, and function 
Similar to C57BL/6 mice (94, 106, 108, 109) (Fig. 2.1), we found that NOD mouse 
thymic DC expressed significantly higher levels of MHC I, MHC II, CD40 and CD86, but 
not CD80, compared to resting splenic DC, and also more efficiently stimulated CD4+ and 
CD8+ T cell proliferation (Fig. 2.2). We hypothesized that the increased activation and 
maturation status of thymic DC is regulated by cognate interactions with SP. Accordingly, 
thymic DC from NOD.TCR-/- mice, in which CD4SP and CD8SP development is blocked 
were studied. While overall thymus cellularity is unaffected by TCR deficiency (113, 114), 
the frequency and number of thymic CD11chi cDC were reduced 3- to 5-fold in NOD.TCR-
/- versus NOD mice (Fig. 2.3A,B); pDC were unaffected, however. We also investigated 
whether DC localization was disrupted in the NOD.TCR-/- thymus, which lacks an orderly 
medulla (101, 103, 114). As expected, the majority of CD11c+ thymic DC resided in the 
well-organized medulla of NOD thymi. In comparison, NOD.TCR-/- thymi contained only 
small, disorganized medullary “islands” in which CD11c+ cells were enriched (Fig. 2.3C,D).  
Further analyses confirmed that both cDC and pDC predominantly localized to the medulla 
in NOD and NOD.TCR-/- thymi (Fig. 2.4). Thus, the organization of DC in NOD.TCR-/- 
thymi mirrors that of the decreased and disrupted medulla, suggesting that thymic DC 
cellularity is linked to medulla size. 
Next, the activation and functional status of thymic DC in NOD.TCR-/- mice were 
assessed. NOD.TCR-/- versus NOD thymic cDC expressed decreased MHC II, CD40 and 
CD86 whereas CD80 levels remained unchanged (Fig. 2.3E). Interestingly, constitutive 
expression of IL-12, a cytokine implicated in the deletion of CD4SP (115, 116) was readily 
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detected in NOD thymic cDC, especially CD8+ cDC; however the frequency of IL-12-
producing thymic CD8+ cDC was decreased 2-fold in NOD.TCR-/- mice (Fig. 2.3F). 
ELISA confirmed that IL-12p70 was secreted by thymic DC (N.A. Spidale and R. Tisch, 
unpublished observations). To test DC stimulatory capacity, CD8+ cDC, SIRP+ cDC, and 
pDC were FACS-sorted from NOD and NOD.TCR-/- thymi, pulsed with sBDC agonist 
peptide, and then co-cultured with BDC2.5 CD4+ T cells. NOD CD8+ cDC induced 
significantly more BDC2.5 CD4+ T cell proliferation than NOD.TCR-/- CD8+ cDC (Fig. 
2.3G,H). BDC2.5 CD4+ T cell proliferation was also increased by NOD versus NOD.TCR-/- 
SIRP+ cDC although this trend did not reach statistical significance. Thymic pDC from 
either NOD and NOD.TCR-/- mice induced only low levels of proliferation. Overall, these 
data indicate that thymic cDC but not pDC number, phenotype, and function are significantly 
altered in the absence of SP. With the latter in mind our subsequent efforts focused on thymic 
cDC. 
 
2.4.2 Ag-specific feedback regulates homeostatic thymic cDC maturation  
Mature CD4+ and CD8+ T cells provide distinct modes of feedback to regulate 
peripheral DC maturation and effector function during a cognate immune response. 
Accordingly, whether CD4SP and CD8SP have distinct effects on thymic cDC homeostasis 
was studied using BDC2.5/TCR-/- and CL4.scid mice in which only CD4+ T cells or CD8+ 
T cells develop, respectively.  Despite a significant SP thymocyte pool, thymic cDC from 
either BDC2.5/TCR-/- or CL4.scid mice resembled NOD.TCR-/- thymic cDC (Fig. 2.3), 
marked by a less mature phenotype (Fig. 2.5A,B) and reduced frequency of IL-12+ cells (Fig. 
2.5C,D) compared to wild-type NOD thymic cDC.  
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In BDC2.5/TCR-/- and CL4.scid mice thymocytes undergo positive but minimal (if 
any) negative selection due to the lack of thymic expression of the cognate Ag. This 
suggested that thymic cDC phenotype was regulated by Ag-dependent interactions with 
thymocytes. To test this BDC2.5/TCR-/- and CL4.scid mice were injected with cognate 
peptide, sBDC and HA, respectively, to facilitate direct interaction between DC and 
thymocytes. As expected, thymocyte apoptosis and activation were detected after peptide 
injection (Fig. 2.6). Thymic cDC from BDC2.5/TCR-/- mice injected with 10 g sBDC 
exhibited enhanced activation relative to controls (Fig. 2.5E). Interestingly, at a reduced dose 
of 1 g sBDC, only SIRP+ cDC in BDC2.5/TCR-/- mice upregulated MHC and 
costimulatory molecules (Fig. 2.5E), suggesting increased sensitivity to CD4SP feedback 
and/or enhanced uptake and presentation of soluble Ag. Similarly, thymic cDC expression of 
MHC and costimulatory molecules was increased in an HA dose-dependent manner in 
CL4.scid mice (Fig. 2.5F). Importantly, we confirmed that activation of peripheral T cells is 
not responsible for thymic cDC activation using an adoptive transfer model wherein Ag-
specific T cells were present in peripheral tissues but not the thymus (Fig. 2.7A,B). No effect 
on thymic cDC activation was observed when peripheral T cells were activated by 
administration of cognate Ag (Fig. 2.7C,D).  Notably, similar if not greater levels of serum 
IFN were detected in T cell-recipient NOD.TCR-/- mice compared to BDC2.5/TCR-/- and 
CL4.scid mice after Ag injection (Fig. 2.7E), indicating comparable levels of peripheral T 
cell stimulation. Overall these findings, coupled with a report indicating that thymic DC, not 
mTEC, primarily acquire i.v. injected peptide (80), demonstrate that robust peripheral T cell 
activation has no effect on thymic cDC, and that thymic cDC activation and maturation are 
dependent on an Ag-specific cognate interaction with CD4SP or CD8SP. 
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2.4.3 A role for CD40/CD40L in CD4SP feedback to thymic cDC 
Peripheral DC activation and maturation are regulated in part by CD40 signaling 
induced by binding to CD40L expressed by activated T cells. We hypothesized that 
CD40/CD40L play a similar role in thymic DC:thymocyte crosstalk. First, NOD.TCR-/- 
mice were injected with an agonist CD40 mAb. Expression of MHC II, CD40, CD80, and 
CD86 by thymic cDC was increased in CD40 mAb-treated NOD.TCR-/- mice (Fig. 2.8A). 
Thymic cDC from NOD mice treated with CD40 exhibited little increase in maturation 
despite higher initial CD40 expression (Fig. 2.3E, 2.8A). Thus, ligation of CD40 alone was 
sufficient to induce thymic cDC activation to some extent. To test whether CD4SP regulated 
thymic cDC maturation via CD40L during Ag-specific interactions, BDC2.5/TCR-/- mice 
were injected with a blocking CD40L mAb prior to peptide administration. CD40L 
blockade strongly limited upregulation of MHC and costimulatory molecules by CD8+ cDC 
and, to a lesser degree, by SIRP+ cDC (Fig. 2.8B). In contrast, CD40L blockade had little 
effect on MHC and costimulatory molecule upregulation by thymic cDC in HA-injected 
CL4.scid mice (Fig. 2.8C). Overall, these data show a role for CD40 ligation by CD4SP but 





Our study demonstrates that cognate interactions with SP are critical for regulating 
thymic cDC homeostasis, including thymic cDC abundance (Fig. 2.3A,B). Notably, analyses 
of BrdU incorporation revealed no difference in the rate of thymic DC turnover in 
NOD.TCR-/- versus NOD mice (Fig. 2.9). This suggests that reduced thymic cDC 
cellularity in NOD.TCR-/- mice is due to a developmental defect in the absence of SP, 
which may be especially relevant for intrathymically-derived CD8+ cDC. It is possible that 
mTEC, which are also reduced in TCR-/- mice (101, 103, 117), contribute to thymic cDC 
cellularity and maturation. mTEC may provide a niche through production of chemokines 
such as XCL1 and CCL8 or other factors that regulate thymic cDC localization, recruitment, 
and/or maturation (78, 81, 118). However, thymic DC numbers are normal in 2M- or MHC 
II-deficient mice, the latter exhibiting a reduced mature mTEC pool (103, 117). These 
findings illustrate two key points: either CD4SP or CD8SP are sufficient to sustain DC 
homeostasis, consistent with our findings in peptide-treated BDC2.5/TCR-/- and CL4.scid 
mice (Fig. 2.4), and thymic cDC homeostasis is maintained in the absence of mature mTEC. 
This second scenario is supported by findings demonstrating that thymic cDC maturation is 
unaffected in NOD (Fig. 2.10) and B6 (78) mice lacking Aire expression and thus mature 
mTEC. Therefore, mTEC appear to have only a limited effect on thymic cDC homeostasis. 
On the other hand, these observations support our model that thymocyte feedback is the key 
factor regulating thymic cDC numbers and maturation.  
We propose that SP regulate thymic cDC homeostasis based in part on our 
observations obtained with TCR-/- mice (Fig. 2.3). TCR-/- mice though, also lack 
TCR+DP that may contribute to thymic cDC feedback. While the inability of DC to induce 
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positive selection in vivo (19) likely precludes feedback from the majority (>95%) of DP, 
post-positive selection CD69hi/TCR+ DP may provide feedback to thymic cDC. Positive 
selection induces the migration of CD69hi/TCR+ DP into the medulla (119), which then 
may interact with thymic cDC. CD69hi DP express Cd40lg mRNA (101, 103), which we 
show is associated with feedback mediated by MHC II-restricted thymocytes (Fig. 2.8B). 
However, levels of Cd40lg mRNA expression are reduced ~10-fold compared to CD4SP 
(101), and <4% of CD69hi DP express surface CD40L, compared to nearly 30% of CD4SP 
(104). Consequently, we favor a dominant role for SP in feedback to thymic cDC due to a 
numerical advantage, uniform medullary localization, and significantly higher frequency of 
CD40L+ cells relative to TCR+ DP. Nevertheless, future work is needed to address if 
TCR+ DP indeed contribute to the maintenance of thymic cDC homeostasis. 
Whereas cDC were regulated by SP, thymic pDC were not. Little is known about the 
factors regulating thymic pDC homeostasis. For example, CCL25, which regulates CCR9-
dependent pDC migration to the murine thymus (83), is produced by thymic stroma in an 
AIRE-independent manner (78), and may explain the normal pDC numbers in the 
NOD.TCR-/- thymus (Fig. 2.3A,B). Regulation of migration may be a primary means of 
thymic pDC regulation. Migration of activated versus immature pDC to the thymus is 
significantly reduced (83), which may prevent tolerance induction against foreign Ag during 
infection. Despite an immature phenotype and poor ex vivo stimulatory capacity of thymic 
pDC (Fig. 2.3E,G,H), peptide-loaded pDC transferred i.v. have been shown to delete Ag-
specific SP (83). One interesting scenario is that pDC ferry peripheral self-Ag to the thymus, 
which is then “transferred” to cDC that stimulate negative selection. A similar process of Ag 
transfer occurs from mTEC to DC (75–78).  
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Analyses of NOD.TCR-/- thymic cDC revealed decreased activation status, IL-12 
production, and T cell stimulatory capacity compared to NOD thymic cDC (Fig. 2.3E-H). 
DC maturation was regulated by a cognate Ag-specific interaction with either CD4SP or 
CD8SP (Fig. 2.6E,F). Similarly, SP thymocyte feedback is critical for mTEC differentiation, 
but is mediated exclusively by CD4SP (103). Intriguingly, CD4SP and CD8SP regulated 
thymic cDC homeostasis by distinct mechanisms; CD4SP- but not CD8SP-mediated effects 
were CD40L-dependent (Fig. 2.8). The latter is not surprising since CD8SP express low 
levels of CD40L mRNA relative to CD4SP (101, 103). Of keen interest is defining the nature 
of CD8SP-mediated feedback, as well as determining if thymic cDC subsets are regulated by 
distinct mechanisms. Full characterization of the molecular interactions occurring during 
thymocyte:DC crosstalk will help define the events that influence the efficacy of thymic 
negative selection, and may reveal novel mechanisms by which DC subsets and thymic 





Figure 2.1. Enhanced phenotype and function of thymic versus splenic DC in C57BL/6 
(B6) mice.  (A) Analysis of MHC and costimulatory molecule expression by B6 thymic and 
splenic DC subsets (n=4).  (B) Thymic and splenic DC subsets were FACS-sorted, pulsed 
with OVA323-339 peptide, and then co-cultured with CellTrace-labeled OT-II splenic CD4
+ T 
cells.  (C) Constitutive IL-12 production by DC from B6 mice was assessed as described in 
Materials and Methods.  Error bars represent SEM.  *, P<0.05; **, P<0.01; ***, P<0.001 by 




Figure 2.2. NOD thymic DC are phenotypically and functionally more mature than 
splenic DC.  Gating scheme for all analyses of DC from NOD mouse (A) thymus and (B) 
spleen following isolation as described in Materials and Methods (Section 2.3).  (C-D) 
Comparison of MHC I (H2Db, H2Kd), MHC II (IAg7), CD40, CD80, and CD86 expression 
by NOD thymic and splenic DC gated as shown in Panels A and B (n=4).  Data are 
representative of at least four experiments.  (E-F) Thymic and splenic cDC subsets were 
FACS-sorted as Live/CD11chi/SIRP+/CD8-/lo (SIRP+ cDC) or Live/CD11chi/SIRP-
/CD8+ (CD8+ cDC), pulsed with (E) 10 ng/mL sBDC or (F) 10 ng/mL IGRP peptide, then 
co-cultured with 2.5x105 CellTrace Violet-labeled (E) BDC2.5 CD4+ or (F) 8.3 CD8+ T cells 
for 66-72 hours.  Proliferation of Live/Thy1.2+/CD4+ or CD8+ T cells was determined via 
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CellTrace Violet dilution.  Plasmacytoid DC induced no proliferation under the conditions 
tested (data not shown).  Graphed data are pooled from two independent experiments.  All 





Figure 2.3. Dysregulation of thymic DC in NOD mice lacking SP. (A) Frequency and (B) 
absolute number (+SEM) of thymic cDC and pDC in NOD and NOD.TCR-/- thymi (n=8 
each). (C) Staining of thymic sections for Keratin 5+ mTEC, DEC-205+ cTEC, and CD11c+ 
DC. (D) Quantification of mean CD11c intensity per unit area (+SEM) in the thymic medulla 
and cortex (n=12 sections each). (E) Analysis of MHC and costimulatory molecule 
expression by NOD and NOD.TCR-/- thymic DC. Data are representative of 4 experiments. 
(F) Constitutive intracellular IL-12 expression (+SD from 3 experiments) by thymic cDC 
from NOD and NOD.TCR-/- mice. (G) DC subsets were FACS-sorted from NOD and 
NOD.TCR-/- thymi and BDC2.5 CD4+ T cell proliferation measured. Data are gated on 
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live/Thy1.2+/CD4+ cells from representative co-cultures with 10-2 g/ml sBDC-pulsed DC 
subsets. (H) Division Index (+SEM) calculated from cells proliferating in Panel G. Data 




Figure 2.4. cDC and pDC more heavily localize to the medulla vs. the cortex in both 
NOD and NOD.TCR-/- thymi. A) Thymic sections from NOD and NOD.TCR-/- mice 
were stained with biotin CD11c, purified rabbit Keratin 5, and Alexa Fluor 647 PDCA-1, 
then Brilliant Violet 421 streptavidin and Alexa Fluor 546 goat anti-rabbit. Images were 
acquired on an LSM 710 confocal microscope using ZEN software (Zeiss). The dimensions 
of each image are approximately 2.4 mm x 2.4 mm. Images were analyzed in ImageJ as 
follows:  first, channels were split then converted to binary with automatic thresholding 
(negative = 0, positive = 255). Pixels where PDCA-1 and CD11c overlapped were subtracted 
from the total CD11c image using the Image Calculator to create a new CD11c+PDCA-1- 
(cDC) image. This image was then overlaid with the binary PDCA-1 (pDC) image and 
binary Keratin 5 image to create a new image showing cDC, pDC, and Keratin 5 (images 
shown are the result of this process). B) Mean intensity per unit area of cDC and pDC was 
calculated in the medulla and cortex of NOD and NOD.TCR-/- thymic sections (n=8/group, 
2 sections from each of 4 individual thymi). ***, P<.001 by two-way ANOVA with 
Bonferroni posttest.  
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Figure 2.5. Ag-specific interactions with SP regulate thymic DC activation status. (A-B) 
MHC and costimulatory molecule expression by thymic cDC isolated from NOD and (A) 
BDC2.5/TCR-/- or NOD and (B) CL4.scid mice. (C-D) Constitutive IL-12 production by 
thymic cDC from NOD and (C) BDC2.5/TCR-/- or (D) CL4.scid mice. (E) BDC2.5/TCR-/- 
or (F) CL4.scid mice were injected i.v. with sBDC or HA, respectively, or PBS (Ctrl), and 
16-18 h later MHC and costimulatory molecule expression by thymic DC measured. Values 
are expressed as fold change in mean fluorescence intensity versus Ctrl (normalized to 1). All 
asterisks represent comparison to Ctrl. Data are representative of 3-5 experiments. *, P<0.05; 




Figure 2.6. Apoptosis and activation of thymocytes following peptide injection.  (A and 
B)  BDC2.5/TCR-/- mice were injected with PBS, 1 g sBDC, or 10 g sBDC and then 
rested for 16-18 hours prior to analysis of activated caspases/apoptosis (VAD-FMK+) and 
activation (CD69+) of thymocytes via FACS (n=3/group).  (C and D) CL4.scid mice were 
injected with PBS, 1 g HA, or 5 g HA and analyzed as in Panels A and B (n=3/group).  
Note that no clear delineation of DP and CD8SP thymocytes was observed in these mice, 
thus all CD8+ thymocytes, which expressed high levels of TCR (unpublished observations), 
were analyzed as a single population.  **, P<.01; ***, P<.001 (ANOVA with Bonferroni 
posttest).  CaspACE FITC-VAD-FMK In Situ Marker was purchased from Promega and 
used at a 1:500 dilution.  
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Figure 2.7. Activation of peripheral T cells alone does not activate thymic DC.  (A) 
Experimental design to determine if peripheral T cell activation leads to thymic DC 
activation.  (B) Detection of transferred T cells by characteristic TCR V staining.  Thymus 
panels were gated on total, live thymocytes; spleen panels were gated on live, CD3+Thy1.2hi 
cells.  AT, Adoptive Transfer.  (C-D) Analysis of thymic DC phenotype in NOD.TCR-/- 
mice that received (C) BDC2.5 CD4+ T cells and 5 g sBDC or (D) CL4 CD8+ T cells and 5 
g HA as described in panel A.  (E) IFN concentration in the serum of T cell-injected 
NOD.TCR-/- recipients or BDC2.5/TCR-/- and CL4.scid mice injected with peptide (n=3-
6/group).  *, P<.05 by two-way repeated measures ANOVA with Bonferroni posttest.  
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Figure 2.8. CD40/CD40L partially regulates thymic DC phenotype. (A) NOD and 
NOD.TCR-/- mice were injected i.p. with 200 g agonist CD40 or isotype control (Ctrl) 
mAb, and MHC and costimulatory molecule expression by thymic DC assessed 16-18 h 
later. Inset asterisks represent analysis of Ctrl vs. CD40. (B) BDC2.5/TCR-/- or (C) 
CL4.scid mice were treated daily i.p. for 3 d with 250 g blocking CD40L mAb or PBS 
then, at the time of the final CD40L treatment, injected i.v. with 5 g sBDC (B) or 5 g HA 
(C), and thymic DC expression of MHC and costimulatory molecules measured 16-18 h 
later. Asterisks within histograms represent analysis of PBS + peptide vs. CD40L + peptide. 




Figure 2.9. Thymic DC turnover is not dramatically different in NOD versus 
NOD.TCR-/- mice. A) NOD and NOD.TCR-/- mice were administered BrdU for 2, 5, or 8 
days and then BrdU incorporation by thymic DC subsets was assessed via FACS. Gating is 
based on cells stained with BrdU from mice not administered BrdU (No BrdU). B) 
Summary of data compiled from 3 independent experiments as in (A) showing mean 




Figure 2.10. Thymic DC phenotype is unaffected in AIRE-deficient mice.  Thymic DC 
were isolated from 4-wk-old wild-type NOD and disease-free NOD.AIRE-/- mice and 
expression of MHC II (IAg7), CD40, CD80, and CD86 assessed via FACS.  Graphs show 




CHAPTER 3:  Dendritic cell nibbling may preferentially target surface molecules 
clustered into lipid rafts 
3.1 Summary 
 Dendritic cells (DC) are important antigen presenting cells (APC) in the thymus for 
the maintenance of central tolerance. Unlike mTEC, however, DC are not known to 
intrinsically express significant amounts of PTA. One way in which DC acquire relevant 
antigen (Ag) for presentation to developing thymocytes is via intracellular Ag transfer, or 
nibbling, from mTEC. Despite the significance of this process in central tolerance, the factors 
regulating thymic DC nibbling are poorly understood. Here, we demonstrate that thymic DC 
may preferentially acquire surface molecules densely clustered into lipid raft membrane 
microdomains. Using an MHC-mismatch-based in vitro system, thymic DC were found to 
nibble MHC from TEC and other DC but not B cells. Notably, B cell MHC remained 
inefficiently acquired even when surface expression was increased over 5-fold, indicating 
that acquisition is independent of absolute surface levels. Interestingly, lipid rafts were 
acquired from both TEC and B cells. When a B cell surface molecule, namely IgM, was 
actively clustered into lipid rafts, thymic DC acquired IgM, which was otherwise poorly 
nibbled from resting B cells. These data suggest that thymic DC may preferentially nibble 




The generation of a self-MHC restricted peripheral T cell population purged of 
autoreactivity is a critical step in the development of the immune system. T cell development 
in the thymus thus has several mechanisms in place to ensure that both of these goals are met.  
Thymocytes that have assembled a functional TCR must first be “positively” selected by 
self-MHC presented by cTEC (16). However, this process alone is insufficient to generate an 
appropriate peripheral T cell population. For example, T cells that develop in an environment 
where cTEC are the only thymic source of self-MHC are not tolerized to self-MHC (62). 
Thus, antigen presentation by additional thymic APC, namely mTEC and DC, is critical for 
purging the T cell repertoire of autoreactivity and fostering “normal” T cell development.  
mTEC are a heterogeneous group of cells that can be divided into multiple 
subpopulations, including those expressing relatively low levels of CD80 and MHC II and 
those expressing high levels of CD80 and MHC II (so-called mTEChi) (73). The latter 
mTEChi population is often ascribed the most significance due to expression of the AIRE 
transcription factor. The AIRE protein is noteworthy for its ability to drive expression of 
many peripheral tissue Ag (PTA), which leads to central tolerance induction to these Ag (79, 
120). Interestingly, AIRE also has additional described functions outside of driving PTA 
expression, including potentially promoting mTEC apoptosis (121) and inducing the 
production of a range of chemokines (78). The latter observation has obvious implications for 
driving thymocyte migration into the medulla, but is also important for promoting thymic DC 
localization to the medulla (118), where these cells can interact with and delete self-Ag-
specific thymocytes. Notably, AIRE-dependent chemokines may not simply recruit thymic 
DC into the medulla but also facilitate interactions between mTEC and thymic DC (78). 
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Thus, mTEC make crucial contributions to T cell central tolerance via both direct Ag 
presentation and via driving important thymic cell populations into the medulla. 
Thymic DC are also a critical medullary APC population that are known to promote 
negative selection of thymocytes (19). However, as thymic DC are not known to express 
biologically-relevant levels of AIRE (18, 122), thymic DC have developed other means of 
acquiring relevant self-Ag for presentation in the thymus. Some thymic DC, namely the 
SIRP+ cDC and pDC subsets, can acquire Ag in the periphery and then migrate to the 
thymus to enforce central tolerance (69, 70, 83). In addition the CD8+ cDC and SIRP+ 
cDC subsets can acquire blood-borne Ag for subsequent processing and presentation to 
thymocytes (80, 82); though it has been argued that SIRP+ cDC preferentially acquire 
blood-borne Ag due to ideal intrathymic positioning (81). Interestingly, thymic DC also 
acquire mTEC-derived Ag via intercellular Ag transfer, which may occur consequent to 
mTEC apoptosis or by acquisition of molecules from live mTEC via “nibbling” (75–78). 
While this process has been shown to influence the efficacy of negative selection, little is 
known about the mechanisms governing thymic DC Ag acquisition from mTEC. Moreover, 
it remains unclear whether surface proteins are acquired indiscriminately, or whether there 
are factors that promote selective acquisition of proteins. In this study, we investigated Ag 
acquisition by thymic DC via nibbling using an in vitro system of MHC mismatched TEC 
and thymic DC. In this setting, acquisition of MHC from live TEC by thymic DC was readily 
observed, as was acquisition of MHC from other thymic DC and splenic DC. Uniquely, 
MHC could not be acquired from B cells, and this was found to be independent of the 
relative levels of MHC surface expression. Notably, lipid raft membrane microdomains (also 
known as detergent-resistant membrane domains) could be acquired from TEC and B cells, 
59 
and may play a role in governing nibbling by thymic DC. While surface IgM was not 
acquired from resting B cells, in which IgM is mostly excluded from lipid rafts, active 
clustering of B cell surface IgM to lipid rafts induced nibbling of IgM by thymic DC. Thus, 
lipid rafts may represent a distinct plasma membrane locale targeted by thymic DC for 
surface Ag acquisition via live cell nibbling.  
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3.3 Materials and Methods 
3.3.1 Mice 
NOD/LtJ (NOD), BALB/cJ (BALB/c), NOD.Cg-Tg(TcraBDC2.5, 
TcrbBDC2.5)1Doi/DoiJ x NOD.129P2(C)-Tcratm1Mjo/DoiJ (BDC2.5/C0), and 
NOD.129S2(B6)-Airetm1.1Doi/DoiJ (NOD.AIRE-/-) were originally purchased from the 
Jackson Laboratories and housed under specific pathogen-free conditions at the University of 
North Carolina at Chapel Hill (UNC-CH). All animal procedures were approved by the 
UNC-CH Institutional Animal Care and Use Committee. Mice were used between 4 and 8 
weeks of age.  Both male and female mice were used but sex-matched within an experiment. 
No differences between cells isolated from male or female mice were observed for any assay 
(unpublished observations).  
 
3.3.2 Cell isolation 
For DC isolation, thymi or spleens were harvested and finely minced with a razor 
blade. Following a 30 min room temperature digestion with 1 mg/ml Collagenase D and 20 
g/ml DNAse I (Roche) in R2 (RPMI 1640/2% fetal calf serum [FCS]/10 mM HEPES pH 
7.4) and 5 min incubation with ~10 mM EDTA, dispersed thymic cells were centrifuged 
through an OptiPrep (60% w/v iodixanol; Axis-Shield) gradient (123). Cells were suspended 
in 4 ml of a 15% w/v iodixanol solution, then overlaid with 5 ml of a 12% w/v iodixanol 
solution, then overlaid with magnetic-activated cell sorting (MACS) buffer (PBS/0.5% 
bovine serum albumin/2 mM EDTA). Gradients were centrifuged for 15 min at 600g at room 
temperature, and then low density cells banding at the interface between the 12% w/v 
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iodixanol and MACS buffer were used for purification of DC with CD11c microbeads and an 
AutoMACS separator (Miltenyi Biotec).  
For isolation of TEC, thymi were digested with 1 mg/ml Collagenase D and 20 g/ml 
DNAse I in R2 at 37°C (3 rounds, 15 min each), then for an additional 15 min with 1.25 
mg/ml Collagenase/Dispase (Roche) and DNAse I, followed by incubation with 10 mM 
EDTA for 5 min. Cells were suspended in 4 ml of a 1.115 specific gravity Percoll (GE 
Healthcare) solution, overlaid with 2 ml of a 1.065 specific gravity Percoll solution, then 
overlaid with 2 ml of PBS (specific gravity ~1.0). Gradients were centrifuged for 30 min at 
2700 revolutions per minute at 4°C, and TEC-enriched light density cells banding at the 
interface of the 1.065 Percoll solution and PBS were used for further enrichment of TEC via 
CD45+ cell depletion on an AutoMACS separator.  
B cells and CD4+ T cells were isolated following mechanical dispersion of spleens 
using the EasySep Mouse B Cell Isolation Kit (Stem Cell Technologies) or CD4+ T cell 
isolation kit II (Miltenyi Biotec), respectively. 
 
3.3.3 FACS 
The following mAb and other reagents were purchased from BD Biosciences, 
BioLegend, eBioscience, or Life Technologies and used for FACS:  CD11c (N418), 
CD8 (53-6.7), SIRP (P84), CD45RA (14.8), B220 (RA3-6B2), CD3 (145-2C11), 
CD49b (DX5), CD19 (1D3), erythroid cells (Ter-119), IAk/g7 (10-3.6), IEd (14-4-4S), 
H2Dd (34-2-12), Epithelial cell adhesion molecule (EpCAM, G8.8), CD45.1 (A20), 
CD45.2 (104), IgMa (MA-69), and streptavidin. To label lipid rafts, TEC or B cells were 
incubated with 1 g/ml Cholera Toxin B subunit (CTxB, Life Technologies) in PBS for 15 
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min, then washed extensively.  Cells were Fc receptor blocked (2.4G2) prior to mAb 
staining. Dead cells were excluded from all analyses using propidium iodide or DAPI (Life 
Technologies). Data were acquired on an LSR II (BD Biosciences) and analyzed using 
FlowJo (TreeStar Inc.). Sorting was performed on a MoFlo XDP (Beckman Coulter) and 
population purity was >95%. To analyze proliferation, purified BDC2.5 CD4+ T cells were 
labeled with 5 M CellTrace Violet (Life Technologies), then cultured as indicated in the 
text. 
 
3.3.4 Nibbling Assay 
To examine nibbling in vitro, cells were isolated from MHC-mismatched mice (e.g. 
thymic DC from H2g7 NOD and “donor” TEC, DC, or B cells from H2d BALB/c). In some 
experiments, the donor BALB/c population was labeled with CTxB as described above to 
examine acquisition of lipid rafts. DC and donor cells were then co-cultured for 3-4 h in R10 
(RPMI 1640/10% FCS/4 mM L-glutamine/1x non-essential amino acids/1 mM sodium 
pyruvate/100 units/ml penicillin/100 g/ml streptomycin/55 M -mercaptoethanol/10 mM 
HEPES pH7.4) and analyzed via FACS. In some experiments, a 0.4 m TransWell apparatus 
(Corning) was used wherein DC were seeded in the well and the donor population was 
seeded in the well with the DC or into the TransWell and thus separated from the DC. In 
some experiments, DC were pre-treated with a blocking mAb for scavenger receptor type A 
(SR-A, clone 2F8, AbD Serotec) for 20-30 min, then TEC were added and the cells were co-
cultured as above. 
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3.3.5 Cell stimulation 
 To assess acquisition of IEd and CTxB from activated B cells, BALB/c splenic B cells 
were purified as above and then cultured for 16-20 h with the following stimuli in R10:  10 
g/ml CD40 (clone 1C10, produced in-house), 10 g/ml E. coli lipopolysaccharide (LPS, 
Sigma-Aldrich L2630), 25 g/ml goat anti-mouse IgM F(ab’)2 (Jackson ImmunoResearch), 
or LPS + IgM. Cells were washed extensively then labeled with CTxB and cultured with 
thymic DC as above.   
 To examine the acquisition of IgM during IgM stimulation, Alexa Fluor 647-
conjugated goat anti-mouse IgM F(ab’)2 (IgM.Ax647, Jackson ImmunoResearch) was used 
because unconjugated IgM rendered IgM undetectable using other IgM Ab (unpublished 
observations). Prior to use, IgM.Ax647 was buffer-exchanged against sterile PBS using a 
10,000 Dalton molecular-weight cutoff spin column (Millipore) to remove preservatives. 
Buffer-exchanged IgM.Ax647 was confirmed to retain B cell stimulatory potential as 
assessed by upregulation of MHC II (unpublished observations). Purified B cells were coated 
with titrated concentrations of IgM.Ax647 at 4°C for 20-30 min, washed of excess 
IgM.Ax647, then mixed with purified thymic DC and cultured at 37°C for 3-4 h.  
 
3.3.6 qPCR 
Thymic DC were purified via FACS and RNA isolated using TriZol (Life 
Technologies). DNAse digestion was performed using TURBO DNAse (Ambion), and then 
cDNA was generated using Maxima H Minus Reverse Transcriptase (Thermo Scientific) 
with oligo(dT)18 priming. Quantitative polymerase chain reaction (qPCR) analysis was 
performed on 20 nanograms of cDNA using the Maxima SYBR Green Master Mix (Thermo 
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Scientific) and a MyIQ iCycler (Bio-Rad). Cycling conditions were as follows:  95°C, 10 
min followed by 40 cycles of 95°C, 15 s; 60°C, 30 s; 72°C, 30 s followed by dissociation 
curve analysis. No template and no reverse transcriptase controls consistently yielded no 
amplification, and dissociation curves confirmed only 1 amplicon/primer set. Relative 
expression of Epcam was assessed by the comparative Ct (Ct) method (124) using Hprt as 
the endogenous reference and EpCAM- cDC as the calibrator sample. The following primers 
were produced by the UNC-CH Nucleic Acids Core Facility and used for qPCR:  Epcam 
Forward, 5’ – GCGGCTCAGAGAGACTGTG – 3’; Epcam Reverse, 5’ – 
CCAAGCATTTAGACGCCAGTTT – 3’; Hprt Forward, 5’ – 
GCTATAAATTCTTTGCTGACCTGCTG – 3’; Hprt Reverse, 5’ – 




3.4.1 Thymic DC produce EpCAM intrinsically 
A recent investigation into acquisition of TEC Ag by thymic DC observed a strong 
association between EpCAM positivity on DC and acquisition of a TEC-specific fluorescent 
reporter (77). However, whether the capacity to acquire TEC Ag is restricted to one or more 
specific DC subsets was not addressed. Analysis of EpCAM on thymic DC subsets revealed 
a significant portion of EpCAM+ cells within both the CD8+ and SIRP+ cDC populations 
but no EpCAM+ pDC (Fig. 3.1A-B). Interestingly, some of the EpCAM+ cDC showed 
particularly high levels of EpCAM labeling—levels comparable to those observed on TEC 
(Fig. 3.1A). It was surprising that such a marked amount of EpCAM could be acquired by 
DC. Moreover, whether EpCAM can be expressed by thymic DC per se has not been 
examined. To address this possibility, thymic cDC were FACS-sorted into EpCAM+ and 
EpCAM- populations (Fig. 3.1C) for analysis of Epcam mRNA via RT-qPCR. Strikingly, 
EpCAM+ cDC produced roughly 70-fold more Epcam transcript compared to EpCAM- cDC 
(Fig. 3.1D). Moreover, Epcam transcript levels correlated with surface EpCAM staining—the 
intensity of EpCAM staining on EpCAM+ cDC was at least an order of magnitude higher 
than on EpCAM- cDC (Fig. 3.1A,B). By comparison, TEC themselves expressed >200-fold 
more Epcam than EpCAM- cDC and thus approximately three times the amount as EpCAM+ 
cDC. To extend these findings, EpCAM levels on thymic DC isolated from Aire-deficient 
NOD mice (NOD.AIRE-/-) were examined. AIRE-expression in mTEC has been previously 
shown to regulate transfer of Ag from mTEC to DC in vivo, possibly through regulation of 
chemokine expression that promotes mTEC-DC cognate interactions (78). Comparison of 
NOD and NOD.AIRE-/- thymic DC showed comparable frequencies of EpCAM+ thymic DC 
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subsets (Fig. 3.1E). Together, these data suggest that EpCAM+ thymic DC produce EpCAM 
intrinsically; therefore it is difficult to determine what proportion of EpCAM, if any, is 
acquired from mTEC versus produced intrinsically by thymic DC.   
 
3.4.2 DC can acquire MHC I and MHC II from TEC and DC but not B cells in vitro 
To establish a more controlled system to test the nibbling ability of thymic DC, we 
used an in vitro co-culture system relying on the MHC-mismatch of cells isolated from 
different mouse strains (Fig. 3.2A). In a typical assay, thymic DC were isolated from NOD 
mice (IAg7/IEnull/H2Db) then co-cultured with “donor” TEC, thymic or splenic DC, or B cells 
isolated from BALB/c mice (IAd/IEd/H2Dd). Cells were then labeled with antibodies 
detecting IEd and H2Dd, and acquisition of these molecules by NOD thymic DC was 
examined via FACS. First, the antibodies used to detect IEd and H2Dd showed no 
background staining of NOD DC (Fig. 3.2B-E, upper panels), indicating minimal cross-
reactivity with NOD MHC II or MHC I, respectively. When NOD thymic DC were co-
cultured with BALB/c TEC, significant amounts of both MHC I and MHC II were acquired 
(Fig. 3.2B), with most DC acquiring either both MHC I and MHC II or neither MHC I nor 
MHC II. A similar pattern of acquisition was observed with BALB/c thymic DC as the MHC 
donors, with a trend towards MHC II versus MHC I acquisition (Fig. 3.2C). However, this 
“preference” may be indicative of the relative detection intensity on the donor cell population 
rather than true preference of acquisition, i.e. the MFI of IEd on BALB/c thymic DC is 
greater than the MFI of H2Dd on BALB/c thymic DC under our analysis conditions (Fig. 
3.2F). When BALB/c splenic DC were used as MHC donors, the overall frequency of 
BALB/c MHC+ NOD DC was lower relative to cells cultured with TEC or thymic DC (Fig. 
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3.2D), but acquisition was nonetheless readily detectable. Again, a preference for acquisition 
of MHC II versus MHC I was observed. Strikingly, when BALB/c splenic B cells were used 
as the MHC donors, no acquisition of MHC I or MHC II by thymic DC was observed (Fig. 
3.2E). Similar results were obtained if the acquiring and donor cell MHC haploptypes were 
switched (data not shown). These data indicate that thymic DC can readily acquire both 
MHC I and MHC II from TEC, thymic DC, and splenic DC but, interestingly, not splenic B 
cells. Subsequently, we also compared the relative efficiency of thymic and splenic DC 
nibbling TEC.  Splenic DC also significantly nibbled TEC MHC I and MHC II (Fig. 3.3A).  
While the frequency of BALB/c MHC+ DC was similar between thymic and splenic DC, 
(Fig. 3.3B), significantly more MHC I and MHC I was acquired by thymic DC as assessed 
by MFI (Fig 3.3C). This indicates that the ability to nibble MHC I and MHC II is not unique 
to steady-state thymic DC, although thymic DC may be uniquely efficient nibblers compared 
to splenic DC. 
To further validate this assay design, it was important to determine whether acquired 
MHC molecules were functional for T cell stimulation. To address this, TEC were isolated 
from NOD mice and pulsed with titrated concentrations of sBDC peptide, while thymic DC 
were isolated from BALB/c mice. Thymic DC were co-cultured with peptide-pulsed TEC as 
above, and then thymic DC and TEC were separated via FACS (Fig. 3.4A). Following 
separation, thymic DC and TEC were cultured with responder CellTrace Violet-labeled 
BDC2.5 CD4+ T cells for 3 d, and then proliferation assessed via FACS. As expected, robust 
proliferation of BDC2.5 cells was observed when peptide-pulsed TEC were used as the 
stimulators (Fig. 3.4B). When post-nibbling thymic DC were used, some proliferation above 
background was observed when BALB/c thymic DC that were cultured with unpulsed TEC 
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were cultured with BDC2.5 cells, suggesting a small degree of allogeneic responsiveness. 
However, detectable proliferation was observed in a manner dependent on the peptide 
concentration with which the donor TEC were pulsed (Fig. 3.4B-C). Based on the 
proliferation observed when peptide-pulsed TEC versus post-nibbling thymic DC were used 
as stimulators, we estimate that the stimulatory capacity of post-nibbling DC was 
approximately 10- to 50-fold lower than that of peptide-pulsed TEC. Together, these data 
indicate that acquired peptide-MHC II molecules can be used directly for T cell stimulation. 
We subsequently investigated the factors that may regulate preferential acquisition of MHC 
II from TEC but not B cells by thymic DC. 
 
3.4.3 Thymic DC acquire lipid rafts from TEC and B cells 
Little is known about the factors that regulate the cell-to-cell transfer of MHC 
molecules. In the case of T cell trogocytosis, a process analogous to nibbling whereby T cells 
can acquire peptide-MHC and other molecules from APC, a cognate Ag-specific interaction 
and the formation of an immunological synapse is necessary (125, 126). However, such an 
interaction does not occur between thymic DC and TEC. We hypothesized that other factors 
regulating cell membrane organization may facilitate DC nibbling. To this end, we 
investigated the role of lipid rafts in DC nibbling. Lipid rafts are membrane microdomains 
enriched in certain classes of molecules, including cholesterol, sphingolipids, and other 
glycolipoproteins (127). Interestingly, lipid rafts are critical for various immunologically 
important phenomena, including TCR-MHC interactions, BCR signaling, and Fc receptor 
signaling (128). To investigate lipid rafts, we took advantage of the binding of CTxB to the 
lipid raft ganglioside GM1 (129). BALB/c TEC and B cells were labeled with fluorochrome-
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conjugated CTxB, then co-cultured with NOD thymic DC as above to examine DC 
acquisition of lipid rafts (CTxB) and IEd. Robust acquisition of CTxB was observed by 
virtually all DC that were co-cultured with TEC (Fig. 3.5A). As before, a significant portion 
of DC also acquired TEC-derived IEd. Interestingly, whereas no IEd was acquired from 
BALB/c B cells, essentially all DC could acquire CTxB from B cells (Fig. 3.5B). Thus, lipid 
rafts can be readily acquired from both TEC and B cells. 
 
3.4.4 Thymic DC nibbling of MHC II/lipid rafts is contact-dependent 
To begin to investigate the factors that regulate thymic DC nibbling of MHC II and 
lipid rafts, we analyzed the requirement for cell-cell contact in the acquisition of IEd and 
CTxB. When DC and TEC (Fig. 3.5C) or DC and B cells (Fig. 3.5D) were physically 
separated in a TransWell (TW) apparatus, no acquisition of IEd and an 80-90% reduction in 
the acquisition of CTxB was observed. These data indicate that DC acquisition of MHC II 
and lipid rafts is dependent on cell-cell contact. In this context, it has been previously shown 
that class A scavenger receptor (SR-A) plays a role in regulating Ag acquisition from live 
cells via nibbling by non-human primate DC (130). To address whether SR-A plays a similar 
role in murine thymic DC nibbling of MHC II, a nibbling assay was performed as above with 
or without a blocking SR-A mAb, which completely inhibits macrophage binding of known 
SR-A ligands (131). However, SR-A did not affect thymic DC nibbling of mTEC MHC II 
or lipid rafts (Fig. 3.5E). Therefore, murine thymic DC nibbling of MHC II occurs 
independently of SR-A. 
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3.4.5 Inefficient nibbling of B cell MHC II is independent of absolute level of B cell MHC II 
expression 
The fact that DC can acquire CTxB but not IEd from B cells suggests that B cells are 
not completely resistant to DC nibbling, but rather that there may be something unique about 
B cell IEd that causes it to be inefficiently acquired by DC. One possibility is the absolute 
level of IEd expression, which is about 7-fold lower on splenic B cells than on TEC (Fig. 
3.2F). To address this, we used various B cell activating stimuli, all of which increase IEd 
expression >5-fold (Fig. 3.6A). When B cells were activated via IgM stimulus, a small 
amount of IEd was observed on nibbling DC, while CTxB was acquired to similar levels as 
from Ctrl B cells (Fig. 3.6B). Less IEd was observed on DC cultured with CD40- or LPS-
activated B cells. Interestingly, when B cells were stimulated with IgM and LPS together, 
less acquisition of both IEd and CTxB was observed (Fig. 3.6B), suggesting that LPS 
stimulation is somewhat “inhibitory” when combined with IgM versus IgM alone. 
Nonetheless, the intensity of MHC acquisition by thymic DC cultured with activated B cells 
was far lower than when thymic DC were cultured with TEC (Fig. 3.2B, 3.5A). Overall, 
these data suggest that factors other than the absolute level of MHC II expression regulate the 
ability of MHC II to be acquired by thymic DC. 
 
3.4.6 Strong clustering of IgM to lipid rafts promotes nibbling of IgM by DC 
 Based on the above data, and on other work showing the significance of lipid rafts in 
various immunological processes (128), we hypothesized that lipid rafts may play a role in 
mediating thymic DC nibbling of MHC II. However, considering that a significant portion of 
MHC II is constitutively localized to lipid rafts, including on B cells (132, 133), it is 
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reasonable to conclude that localization of a given molecule to lipid rafts is not sufficient to 
permit subsequent nibbling by thymic DC. To directly examine this question, acquisition of 
another B cell-restricted molecule, surface IgM was examined. In resting B cells, surface 
IgM is minimally associated with lipid rafts; however upon cross-linking with an IgM Ab, 
IgM is rapidly and robustly clustered into lipid rafts (134). First, nibbling of IgM from 
resting B cells was determined using an IgMa specific mAb (recognizing BALB/c-derived 
IgMa but not NOD-derived IgMb). Similar to experiments examining acquisition of IEd from 
BALB/c B cells, minimal IgMa was acquired by thymic DC despite high expression of IgMa 
by B cells (Fig. 3.6C). To address whether actively clustering IgM to lipid rafts could 
promote acquisition by thymic DC, splenic B cells were bound with fluorescent IgM Ab 
(IgM.Ax647) at 4°C to prevent premature IgM internalization, then IgM.Ax647-coated B 
cells were cultured with thymic DC at 37°C to induce IgM clustering to lipid rafts. Under 
these conditions, IgM was acquired by thymic DC in an antibody dose-dependent manner—
under stronger stimulation conditions, more IgM was acquired (Fig. 3.6D). Under the 
conditions used, B cells were strongly labeled with IgM.Ax647 (Fig. 3.6E). These data 
suggest that extensive localization of a surface molecule to lipid rafts may be sufficient to 
promote acquisition by DC via nibbling, though other changes in B cell surface protein 





 While thymocyte development has been extensively studied, many of the mechanisms 
of thymic Ag presentation remain ill-defined. With this study we investigated one 
mechanism regulating thymic Ag presentation—the process of intercellular Ag transfer of 
MHC molecules from mTEC to DC. Initially, we attempted to garner insight into the in vivo 
nibbling of mTEC molecules by thymic DC using EpCAM as a readout. Strikingly, however, 
EpCAM+ thymic DC were found to produce 70-fold more Epcam transcript compared to 
EpCAM- thymic cDC (Fig. 3.1D). In addition, the frequency of EpCAM+ thymic cDC was 
comparable in WT NOD and NOD.AIRE-/- mice (Fig. 3.1E), the latter of which show 
reduced mTEC-to-DC Ag transfer (78). Collectively, these data suggest that thymic cDC 
produce EpCAM intrinsically, though we cannot rule out the possibility that some EpCAM is 
also acquired from TEC. It is notable that surface EpCAM has also been observed on DC in 
peripheral lymphoid organs, such as skin-draining lymph nodes and the spleen (135), neither 
of which possesses many EpCAM+ stromal cells (136). It is interesting to speculate on the 
reason thymic DC produce EpCAM intrinsically. EpCAM is a cell surface glycoprotein that 
mediates homophilic adhesion (137), therefore EpCAM expression by thymic DC could 
facilitate interaction with EpCAM-expressing TEC (or other EpCAM-expressing DC). This 
may explain why high levels of EpCAM were observed on DC that acquired a TEC-specific 
reporter in vivo (77). Whether EpCAM facilitates Ag transfer from mTEC to thymic DC 
could be the subject of future studies. 
 Using an in vitro system to test nibbling, it was found that thymic DC robustly 
acquire MHC from mTEC (Fig. 3.2B), which can be directly used for T cell stimulation (Fig. 
3.4). Based on these experiments, we have estimated that nibbling thymic DC are roughly 
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10- to 50-fold less efficient T cell stimulators than directly peptide-pulsed TEC. This 
efficiency is higher than was estimated in a previous study analyzing peptide-MHC I 
acquisition during bone-marrow derived DC nibbling of other DC (138). There are many 
differences between this and our own study, including analysis of MHC I versus MHC II, the 
identity of both the donor and the nibbling populations, and likely the affinity with which the 
TCR transgenic T cells used as responders recognize the cognate peptide-MHC. Whether the 
identity of the donor population regulates the efficiency with which nibbling DC can 
stimulate T cells or thymocytes is unknown. Given identical levels of Ag, our data would 
suggest that DC that have nibbled mTEC would be more efficient stimulators than DC that 
have nibbled other DC, based on the relative acquisition of MHC I and MHC II when these 
cells are cultured together in vitro (Fig. 3.2B-D). Moreover, it is currently unknown whether 
Ag transfer occurs between thymic DC subsets in vivo. Since two of the three thymic DC 
subsets are migratory (69, 70, 83), this raises the possibility that Ag acquired in the periphery 
may then be transferred to intrathymic DC for presentation to thymocytes. This is a 
particularly attractive possibility in the case of thymic pDC; cognate thymocyte deletion was 
observed when peptide-pulsed pDC were transferred i.v. (83), yet thymic pDC are poor T 
cell stimulators compared to thymic cDC ex vivo (139). Formal examination of this 
possibility warrants future investigation. 
 Are there signals or factors that govern nibbling of specific molecules, while leaving 
others unaffected? Our data suggest that this may indeed be the case, and that the specific 
“signal” may involve membrane organization in the form of lipid rafts, which are readily 
transferred from both TEC and B cells to thymic DC (Fig. 3.5A-B). Notably, this is the first 
investigation to consider the role of membrane organization; previous investigations have 
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relied on general lipophilic dyes that label the entire membrane (130, 140). It is currently 
unclear, however, whether lipid rafts are “preferentially” transferred versus non-raft 
membrane microdomains. It is also possible that, while lipid rafts are certainly acquired by 
nibbling DC, localization of proteins to lipid rafts is not a prerequisite for acquisition. This 
idea is inferred from experiments in which both MHC I and MHC II are acquired from TEC 
but not B cells (Fig. 3.2), as MHC II is proposed to constitutively localize to lipid rafts to 
some degree (132, 141) while MHC I is excluded from lipid rafts (133). Yet, induced 
clustering of IgM to lipid rafts on B cells via IgM Ab crosslinking promoted acquisition of 
IgM by nibbling DC (Fig. 3.6D). Thus, these data suggest that there may be a highly dynamic 
relationship between cell surface Ag organization and DC nibbling.  
 It is interesting to speculate on the advantage gained by the immune system via cell-
to-cell Ag transfer, particularly in the thymus. Through the production of various PTA driven 
by AIRE, mTEC promote tolerance to a range of Ag that would not otherwise be available 
during thymocyte development (18, 73). While some studies have indicated that mTEC 
possess robust T cell stimulatory capacity ex vivo (142) and contribute in a direct, Ag 
presentation-mediated manner to the deletion of thymocytes specific for AIRE-driven neo-
Ag (79), other studies have documented a necessary role for Ag-transfer to bone marrow-
derived cells—most likely DC—for full tolerance induction to mTEC-expressed Ag (75, 77, 
78). Perhaps one main reason for the necessity of Ag transfer, especially in the context of 
MHC II Ag presentation, reflects classical Ag processing and presentation pathways. Ag 
acquired by DC via nibbling could more efficiently enter MHC II processing pathways as 
exogenous Ag, whereas these Ag would most likely enter MHC I processing pathways as 
endogenous Ag in mTEC. Interestingly, mTEC have recently been characterized as having a 
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high level of constitutive macroautophagy (143), which promotes presentation of endogenous 
Ag via MHC II (144). Thus, it is most likely that direct Ag presentation by mTEC and 
indirect Ag presentation consequent to transfer of Ag to DC operate concurrently to enforce 
central tolerance to mTEC-expressed Ag. Further understanding of the mechanisms by which 
thymic DC nibbling of mTEC is regulated will help to refine our understanding of the 





Figure 3.1 EpCAM+ thymic cDC produce Epcam intrinsically. A) Thymic DC were 
enriched and surface EpCAM levels were assessed via FACS.  Thymic DC are gated from 
Live/Lin-/CD11chi (cDC) or Live/Lin-/CD11cint/CD45RA+ (pDC). Gate shown on Lin-
/CD11c- cells represent a small number of TEC that are also enriched during DC isolation. 
Lin = CD3/CD19/DX5/Ter-119. The EpCAM+ gates were set based on EpCAM staining of 
Lin- cells, which include TEC (right-most panel). B) Data compiled from a representative 
analysis as in (A). n=3. Representative of at least 3 independent experiments. C) 
Representative pre-sort and post-sort analysis of EpCAM- and EpCAM+ cDC used for 
subsequent RT-qPCR analysis of Epcam transcript. Cells are gated on Live/CD45+/CD11chi. 
D) Relative expression of Epcam by thymic DC (normalized to EpCAM- cDC = 1). Data are 
pooled from 3 independent experiments. E) Thymic DC were enriched from NOD and 




 Figure 3.2 Thymic DC can nibble MHC I and II from TEC and DC but not B cells. A) 
Cartoon of Nibbling Assay design. Thymic DC are isolated from NOD mice while TEC are 
isolated from BALB/c mice. The cells are co-cultured for 3-4 h and then DC acquisition of 
IEd and H2Dd is assessed. B-E) Staining for IEd and H2Dd on NOD thymic DC after co-
culture with BALB/c B) TEC, C) thymic DC, D) splenic DC, or E) splenic B cells. All cells 
were cultured at 1:1 ratios except for TEC (1:2 TEC:DC). Data are representative of 2-3 
experiments. F) Level of IEd and H2Dd expression by donor cell populations used in (B-E). 
Donor cells were not analyzed side-by-side, but each graph pairs with representative nibbling 
analysis shown in (B-E). 
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Figure 3.3 Splenic DC also nibble MHC I and II, but less efficiently than thymic DC. A) 
NOD thymic and splenic DC were isolated and then co-cultured with BALB/c TEC as in Fig. 
3.2A for analysis of DC nibbling of IEd and H2Dd. Representative graphs show culture at 1:2 
(TEC:DC) ratio. B) Percent IEd+ and H2Dd+ of NOD thymic and splenic DC after co-culture 
with BALB/c TEC. C) MFI of IEd and H2Dd on nibbling thymic and splenic DC. DC were 




Figure 3.4 Peptide-MHC II nibbled from TEC are functional. A) Representative pre-sort 
and post-sort analysis of BALB/c thymic DC after 4 h culture with peptide-pulsed NOD TEC 
(1:1 TEC:DC).  Cells are gated on Live cells. All CD11c+ DC sorted were also CD45.2+. B) 
Thymic DC and TEC were separated via FACS after co-culture for 4 h, then cultured for 3 d 
with CellTrace Violet-labeled BDC2.5 CD4+ T cells. TEC were used at a 1:10 (TEC:T cell) 
ratio, and DC were used at a 1:2 (DC:T cell) ratio. BDC2.5 cells were held at a constant 
1x105/well. Cells are gated on Live/Thy1.2+/CD4+ cells. C) Data pooled from 3 independent 




Figure 3.5 DC nibble lipid rafts from TEC and B cells in a contact-dependent manner. 
A-B) NOD thymic DC were purified and co-cultured with CTxB-labeled A) TEC (1:2 
TEC:DC) or B) splenic B cells (1:1 B:DC) from BALB/c mice, and DC acquisition of IEd 
and CTxB was assessed via FACS. Data are representative of 3 experiments. C) BALB/c 
TEC were isolated and CTxB labeled as in (A), then co-cultured with DC (1:2 TEC:DC) in a 
0.4 m TransWell (TW) apparatus as indicated. D) BALB/c B cells were isolated, labeled 
with CTxB, and then co-cultured with NOD DC (1:1 B:DC) in a TW apparatus as indicated 
in (C). Data are representative of 2-3 experiments. E) Thymic DC were pre-incubated with or 





Figure 3.6 Acquisition of MHC II and IgM from activated B cells. A) BALB/c B cells 
were purified and stimulated as indicated for 16-20 h, and then expression of IEd analyzed 
via FACS. Histogram is gated on Live/CD19+ B cells. Inset values represent IEd MFI. B) 
BALB/c B cells stimulated as in (A) were co-cultured with NOD thymic DC (1:1 B:DC), and 
DC acquisition of IEd and CTxB examined. Data are representative of 2-3 experiments. C) 
Nibbling of BALB/c-derived IgMa from resting splenic B cells by NOD thymic DC. Bottom 
left panel indicates level of IgMa on BALB/c B cells used in the assay. D) B cells were 
purified, coated with the indicated concentration of IgM.Ax647, washed, and then co-
cultured with NOD thymic DC. DC acquisition of IgM was then assessed via FACS. E) 




CHAPTER 4:  Discussion 
DC contribute to both immunity and tolerance in many critical ways. Original studies 
did not identify DC in the thymus (145) on the basis of adherence properties and cytosolic 
organelle composition as assessed via phase contrast microscopy. As techniques for 
identifying cells have progressed, we now know that DC do inhabit the thymus and 
contribute to both thymocyte clonal deletion (19) and tTreg induction (94). The studies 
presented herein further enhance our understanding of thymic DC by illuminating the factors 
regulating thymic DC homeostasis and antigen acquisition. 
 In the first part of our study, the factors regulating thymic DC homeostasis were 
studied. It was found that feedback during Ag-specific interactions with SP thymocytes was 
critical for fostering normal thymic DC numbers, phenotype, and function. In this context, 
we employed two model systems:  1) NOD.TCR-/- mice, in which thymocyte development 
is blocked at the immature TCR- DP stage, and 2) TCR transgenic mice into which cognate 
Ag was injected. The second model system used provides many interesting opportunities for 
future studies. While our data show that TCR-MHC interaction is necessary for feedback to 
occur, we subsequently identify CD40L as the primary molecular mechanism during CD4SP-
mediated feedback. The role of affinity/avidity of the cognate TCR-MHC interaction during 
DC:thymocyte crosstalk was not examined. This could be addressed by using the same TCR 
transgenic mice and injecting peptides of differing affinities, or by employing additional 
TCR transgenic models in which the affinity of the cognate TCR-MHC interaction varies. 
Such studies may determine an “affinity threshold” at which Ag-specific interactions provide 
sufficient feedback to promote thymic DC maturation. Also in this context, it is worthwhile 
to note that the effects of ligation of CD40 by an agonist mAb and the feedback provided 
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during cognate TCR-MHC interaction were not identical (Fig. 2.5E-F, 2.8A). Thus, while 
CD40L is necessary during Ag-specific interactions with CD4SP thymocytes (Fig.2.8B), 
additional factors are also likely involved. Further addressing the relationship between TCR-
MHC affinity and DC:thymocyte crosstalk could help to identify additional factors involved 
in thymocyte feedback to DC. 
 In our studies of cognate Ag administration to TCR transgenic mice, we note 
significant activation and apoptosis of thymocytes under the conditions used (Fig. 2.6). Thus, 
our data support a model in which feedback to DC is provided specifically during 
interactions most consistent with negative selection. However, as thymic DC also induce 
tTreg induction (94), it is possible that feedback could be provided during interactions 
resulting in tTreg formation. To our knowledge, it is currently unknown whether thymocytes 
undergoing tTreg induction upregulate/express a similar array of surface molecules as 
thymocytes undergoing negative selection, though both outcomes are dependent on cognate 
Ag recognition by thymocytes. Notably, however, CD40-CD40L interactions are critical for 
normal development of tTreg cells (96, 146). Thus, it seems likely that DC:thymocyte 
interactions resulting in either negative selection or tTreg induction would provide feedback 
to promote thymic DC maturation. 
 One highly novel aspect of our studies is the identification of a role for CD8SP-
derived feedback in regulating the homeostasis of thymic DC (Fig. 2.5F); by comparison, 
mTEC only accept feedback signals from CD4SP (103). Not surprisingly, CD8SP feedback 
was found to be independent of CD40L (Fig. 2.8C) (101, 104). Thus, the identification of the 
molecular mechanism of CD8SP-derived feedback to thymic DC is of great interest and 
significance. Due to the utility of mAb blockade in identifying CD40L as a molecular 
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mechanism of CD4SP-derived feedback (Fig. 2.8B), a similar approach in CL4.scid mice 
could be used to identify the molecular mechanism of CD8SP-derived feedback. 
Interestingly, our findings with CD4SP and CD40L identify an analogy between peripheral 
CD4+ T cell and CD4SP feedback during cognate interactions with DC. Could a similar 
relationship between CD8+ T cell and CD8SP feedback exist? In this scenario, granulocyte-
macrophage colony-stimulating factor (GM-CSF) may represent an interesting candidate for 
investigation during CD8SP feedback to DC. GM-CSF has recently been shown to promote 
CD40-independent DC activation during cognate CD8+ T cell:DC interactions (147), and a 
neutralizing GM-CSF mAb is readily available and efficacious in vivo (148). Further 
candidates could be identified by transcriptional or proteomic profiling of CD8SP 
thymocytes, or by use of existing resources such as the Immunological Genome Project 
(www.immgen.org) (149, 150). These approaches represent promising means of further 
understanding the molecular mechanisms of DC:thymocyte crosstalk. 
 In the second part of our study, the factors regulating thymic DC nibbling of mTEC 
MHC were investigated. We found that mTEC serve as uniquely efficient MHC donors for 
nibbling DC, whereas B cells are inefficient MHC donors. It seems likely that this 
mechanism has developed purposefully, possibly to overcome or work in concert with the 
relatively poor inherent stimulatory capacity of mTEC via MHC II-mediated Ag presentation  
(75, 77, 144). In fact, the thymic medulla has specific mechanisms in place to foster such 
interactions between mTEC and DC. Certain chemokines are produced by mTEC to promote 
thymic DC migration into the medulla (78, 118), many in an AIRE-dependent manner. This 
could further promote preferential interaction with AIRE-expressing mTEC, which produce 
many critical PTA to which central tolerance must be enforced (18, 151, 152). Furthermore, 
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DC in the medulla are typically observed tethered to thymic stromal cells (153), which may 
facilitate extensive Ag exchange with mTEC in vivo. As thymocytes also utilize stromal cells 
as “highways” for migration throughout the thymus (153, 154), DC are also optimally 
positioned for presentation of Ag—whether produced intrinsically or acquired from mTEC—
to medullary thymocytes. Thus, the thymic medulla represents a unique environment 
designed to facilitate extensive interaction between mTEC, DC, and developing thymocytes 
and promote central tolerance. 
 As mentioned above, resting B cells served as poor donors during nibbling as 
assessed by the acquisition, or lack thereof, of both surface IgM and MHC (Fig. 3.2, 3.6). On 
the other hand, when IgM was actively clustered to lipid rafts via Ab crosslinking, 
acquisition of IgM was observed (Fig. 3.6D). These results raise interesting questions as to 
how DC define which molecules should be acquired versus ignored during nibbling. Could 
part of this preference be for densely clustered surface molecules? Dense clustering of 
surface receptors is typically induced by extensive interaction with a cognate ligand (132), 
thus heavily clustered molecules could represent molecules of the greatest utility in a given 
environment. Actively ignoring non-clustered surface molecules could help prevent 
acquisition of irrelevant molecules by DC. Interestingly, DC have also been shown to acquire 
intracellular Ag (130, 140), including nuclear self-Ag (77). It is tempting to speculate that 
heavy clustering of intracellular Ag could also facilitate acquisition by DC. For example, 
prior to export to the cell surface, peptide-MHC II complexes accumulate in discrete 
intracellular vesicles (155). Investigating whether distinct signals regulate acquisition of 
surface versus intracellular Ag will help to further understand the regulation of thymic DC 
Ag acquisition and presentation during central tolerance. 
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 When taken as a whole, the topics studied herein illustrate the complexity of APC 
biology in the thymus. Historically, much of the discussion of thymic Ag presentation has 
focused on whether a “division of labor” exists among cTEC, mTEC, DC, or macrophages 
(156). While it is clear that this may be the case when comparing cTEC to medullary APC 
such as mTEC and DC, it also now appears evident that this is most likely not the case when 
comparing mTEC and DC (157). Furthermore, it is also clear that there is an inextricable 
linkage between thymocyte negative selection and the maintenance of thymic APC 
homeostasis: in the absence of signals provided by negatively selected thymocytes, thymic 
APC (both mTEC and DC) are significantly perturbed, and in the absence of “normal” 
thymic APC, negative selection is less efficient. The level of complexity of thymic Ag 
presentation and the regulation of thymic APC homeostasis ensures that additional secrets of 
central tolerance are yet to be uncovered. Continued exploration of these topics is crucial to 
our understanding of the means by which T cell tolerance is maintained.  
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